Evidence map›Paper›PMID 33201597›Full record

ArticleESC heart failure2021

Appropriateness rating for the application of optimal medical therapy and multidisciplinary care among heart failure patients.

Satoshi Shoji, Shun Kohsaka, Yasuyuki Shiraishi, Shogo Oishi, Mahoto Kato, Shigehito Shiota, Yasuko Takada, Atsushi Mizuno, Dai Yumino, Hiroyuki Yokoyama and 2 more

Open access · goldAbstract read
In one paragraph

Article in ESC heart failure, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.7field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 9 institutions in 2 countries.

Satoshi ShojiDepartment of Cardiology, Keio University School of Medicine, 35 Shinanomachi Shinjuku-ku, Tokyo, 160-8582, Japan.ORCID 0000-0002-2223-7215
Shun KohsakaDepartment of Cardiology, Keio University School of Medicine, 35 Shinanomachi Shinjuku-ku, Tokyo, 160-8582, Japan.
Yasuyuki ShiraishiDepartment of Cardiology, Keio University School of Medicine, 35 Shinanomachi Shinjuku-ku, Tokyo, 160-8582, Japan.
Shogo OishiDepartment of Cardiology, Himeji Cardiovascular Center, Himeji, Japan.
Mahoto KatoSakakibara Heart Institute, Tokyo, Japan.
Shigehito ShiotaDepartment of Rehabilitation, Hiroshima University Hospital, Hiroshima, Japan.
Yasuko TakadaDepartment of Nursing, National Cerebral and Cardiovascular Center, Suita, Japan.
Atsushi MizunoDepartment of Cardiology, St Luke's International Hospital, Tokyo, Japan.
Dai YuminoYumino Heart Clinic, Tokyo, Japan.
Hiroyuki YokoyamaYokoyama Medical Clinic, Higashimatsuyama, Japan.
Noboru WatanabeDepartment of Cardiology, Hokushin General Hospital, Nagano, Japan.
Mitsuaki IsobeSakakibara Heart Institute, Tokyo, Japan.ORCID 0000-0003-3447-563X
Keio University Hospital · JPSakakibara Hospital · JPHamamatsu Medical Center · JPHimeji University · JPHiroshima University Hospital · JPHokushin General Hospital · JPNational Cerebral and Cardiovascular Center · JPSt. Luke's International Hospital · JPUnited Heart and Vascular Clinic · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimsClinical guidelines for improving the patients' quality of care vary in clinical practice, particularly in super-aging societies, like in Japan. We aimed to develop a set of appropriate-use criteria (AUC) for contemporary heart failure (HF) management to assist physicians in decision making. METHODS AND

resultsWith the use of the RAND methodology, a multidisciplinary writing group developed patient-based clinical scenarios in 10 selected key topics, stratified mainly by HF stage, age, and renal function. Nine nationally recognized expert panellists independently rated the clinical scenario appropriateness twice on a scale of 1-9, as 'appropriate' (7-9), 'may be appropriate' (4-6), or 'rarely appropriate' (1-3). Decisions were based on clinical evidence and professional opinions in the context of available resource use and costs. An interactive round-table discussion was held between the first and second ratings; the median score of the nine experts was then assigned to an appropriate-use category. Most clinical scenarios without strong evidence were evaluated as 'may be appropriate'. Frailty assessments in elderly patients (age ≥ 75 years), regardless of the HF stage, and advanced care planning in patients with stage C/D HF, regardless of age, were considered 'appropriate'. For HF with reduced ejection fraction, beta-blocker administration in elderly patients (age ≥ 75 years) with heart rate < 50 b.p.m. and mineral corticosteroid receptor antagonist use in elderly patients (age ≥ 75 years) with an estimated glomerular filtration rate < 30 mL/min/1.73 m

conclusionsThe HF management AUC provide a practical guide for physicians regarding scenarios commonly encountered in daily practice.

Indexed as

Heart FailureAgedHumansJapanAppropriate-use criteriaClinical scenariosHeart failureRAND

Identifiers

PMID33201597
PMCPMC7835502
OpenAlexW3102126931

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.